At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 291 enrolled
Drug / intervention
Dexamethasonedrug
Likely dose
Dexamethasone 10 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Use of a Single, Low-dose Dexamethasone in Total Knee Arthroplasty
In Brief
A Phase 4 clinical trial evaluating Dexamethasone for Osteoarthritis, Knee. Completed, enrolled 291 participants across 1 site.
Detailed Summary
This study was conducted to determine the efficacy of an additional preemptive, single, low-dose dexamethasone in terms of incidence and severity of postoperative nausea/vomiting (PONV), pain level, and the safety in terms of wound complications in patients managed with our antiemetic protocol based on Ramosetron following TKA.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Knee
CountriesSouth Korea
Collaborators--
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2011
Primary CompletionDec 2011
Study CompletionJan 2012
First PostedJun 2012
TodayJul 2026
First PostedJun 6, 2012
Enrollment StartApr 1, 2011
Primary CompletionDec 1, 2011
Study CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 14.1 years ago
Interventions
Dexamethasonedrug
Dexamethasone 10 mg intravenous administration